GlassScriptPhysician profile
David R Clark
NPI 1194113464
$2,176.43
in general payments reported to CMS, 2019-2025
17 companies · $993 in 2025
The $993 reported for 2025 was more than what 83% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $269 · 2022: $267 · 2023: $273 · 2024: $374 · 2025: $993.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,411 · Travel and Lodging: $184 · Education: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,411.04 |
| Travel and Lodging | $184.36 |
| Education | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $884.77 | 2024-2025 | Synchromedii, Inceptiv, Intellis Adaptivestim |
| Si-Bone, INC. | $503.55 | 2021-2025 | |
| Boston Scientific Corporation | $297.97 | 2021-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Novocure INC. | $67.67 | 2023-2025 | Optune Gio, Optune |
| Microtransponder, INC. | $58.01 | 2025 | |
| Nevro Corp. | $50.08 | 2024 | Senza |
| Abbott Laboratories | $47.58 | 2024-2025 | Proclaim, Eterna |
| Ebi, LLC | $44.47 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Solventum Corporation | $36.17 | 2025 | Prevena |
| Stryker Corporation | $34.58 | 2022 | |
| Horizon Therapeutics Plc | $33.34 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $28.23 | 2024 | Zilretta, Iovera, Exparel |
| Lemaitre Vascular, INC. | $26.53 | 2023 | Anastoclip Gc 8cm (Medium) |
| Highridge Medical LLC | $20.77 | 2024 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Aesculap, INC. | $14.56 | 2023 | M.Blue |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $14.15 | 2024 | Synthecel, Matrixneuro |
| Ossur Americas, INC. | $14.00 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Clark listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.